SSY Group (HKG:2005) obtained registration approvals for Bilastine and Sodium Picosulfate from China's National Medical Products Administration to become bulk drugs for preparations on the market, a Thursday Hong Kong bourse filing said.

Bilastine is mainly used for the symptomatic treatment of urticaria, while sodium picosulfate is used to cleanse the colon before surgical examination.